5 benefits of adopting digital temperature monitoring solutions

Digital temperature monitoring along every step of the pharmaceutical supply chain is quickly becoming the new norm. Government guidelines like the EU’s Good Distribution Practices (GDP) and the guidelines of UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have seen to increased uptake of digital temperature monitoring across the Europe’s pharmaceutical industry.
The covid-19 pandemic and the race for a vaccine brought the importance of digital monitoring to the fore.

Digitalization and transformation of your supply chain

It cannot be stressed enough that the world cannot afford wasting products due to temperature deviations while delivering the much sought after covid-19 vaccines. The covid-19 pandemic and the need to activate what was likely be the world’s most extensive delivery of vaccines, together highlight the urgency of adopting more effective temperature monitoring solutions. There was no time to lose.  

Below are some benefits companies in the pharmaceutical industry stand to gain by adopting digital temperature monitoring solutions.

Enhanced supply chain visibility

Digital temperature monitoring solutions, like TSS cloud-based solution have the capacity to record data of vastly improved quality. The combination of rich data sets, powerful analytics tools, and intuitive reports enable you to compare and analyze your supply chain. As Niclas Ohlsson, CEO of TSS, points out:

“Data collected with the facilitation of a digital system give a full view of the supply chain, providing an unprecedented opportunity to understand interactions, dependencies, and constraints along the chain. Insight from this data can be harnessed to refine the efficiency, cost, and sustainability of the supply chain, potentially reducing operational times and cost”.

‍

Transform end-to-end drug delivery

With cloud-based temperature monitoring, you can track the distribution of drugs meant for clinical trials or direct-to-patient delivery along every step of the journey to its destination. Gone are the days when critical temperature-changing or integrity altering incidents could occur unnoticed and unmitigated. The data collected by using temperature monitoring digitally, help to flag such incidents quicker, make fact based decisions on excursions and mitigate measures activated to not only ensure safe delivery but also assess that the drugs delivered are safe for use.  

How does digital monitoring cut excursion evaluation time?

Evaluation and notification are necessary steps for determining if and what action should be taken if temperature-sensitive pharmaceutical products spend time outside acceptable temperatures during transit. Cloud-based digital temperature monitoring solutions, such as the one provided by TSS, are able to drastically reduce the time it takes to evaluate temperature deviations and speeding up notification times within the window of time when critical decisions can be taken. Lars Norbert of Novo Nordisk notes that prior to their adoption of TSS’ automated and digital monitoring solution, TSS Clinical Module

“…it would take days to get this process and evaluate it, and now we’re down to seconds…”

How does digital temperature monitoring reduce product waste?

Imagine having to discard a large shipment of Covid-19 vaccines or insulin because a temperature deviation was observed during transit, rendering the entire stock unsafe for use. Imagine, also, that duplicate shipments of vaccines were delivered because an initial shipment was wrongly deemed unfit for use, necessitating the delivery of an excess second shipment, which may have to be discarded.  

Insiders of the pharmaceutical industry are familiar with these scenarios and the monumental costs companies involved stand to incur.

Access to comprehensive data through cloud-based temperature management solutions help pharma companies to significantly reduce the possibility of such waste by improving supply chain efficiency. As an example, using the TSS cloud temperature monitoring solution and data loggers from TSS, GlaxoSmithKline has saved £4 million annually.  

Access to customized monitoring solutions

Generic solutions are sometimes not ideal for specific pharmaceutical supply chains. Not only do pharmaceutical supply chains vary depending on the drug involved, but there are also often other relevant factors peculiar to a supply chain which are related to transit routes, transit terrains, etc. This is where customized monitoring solutions come into play.

We go beyond providing generic temperature monitoring solutions. Working with pharma for pharma, in close collaboration with some of the world leading pharmaceutical companies, we have developed customized cloud-based digital monitoring solutions suited to the specifics of a particular pharmaceutical supply chain. TSS and Novo Nordisk recently collaborated on a digital, automated temperature monitoring solution, the TSS Clinical Module which, in collaboration with relevant staff at Novo Nordisk, was easy to deploy and manage. The importance of this ease of use cannot be overstated as time and resources which would otherwise have been spent on training and onboarding activities have instead, been conserved.

In many ways, digital temperature management is growing in the pharmaceutical industry and in the era of covid-19, it is plain to see why. The good news is that finding an ideal solution for your company is now much easier than before. To find out just how easy it can be to start the digitalization and transformation of your supply chain, schedule a consultation meeting with us today.

You may also be interested in

A view of Earth from space with a digital network overlay, representing the future of global temperature monitoring.

White paper: the future, today - the next generation of temperature monitoring

New technologies for tracking and temperature logging hold great potential, but which to choose? Get a copy of our latest white paper.
Read moreDownload Whitepaper
The TSS company logo, representing a change in the company's management.

Change in the Management of TSS

We are thrilled to announce a new chapter at TSS as we bid farewell to our esteemed CEO, Niclas Ohlsson.
Read moreDownload Whitepaper
A stethoscope overlaid with data charts, illustrating how visibility and automation can reduce disruptions from temperature excursions.

Visibility and automation: reducing disruption due to temperature excursions

The Covid-19 pandemic has placed a global spotlight on pharmaceuticals and the importance of temperature monitoring. The large-scale vaccination programs being rolled out across the world depend on operators and distributors being able to monitor and manage temperatures effectively. It has also shown just how challenging this can be.
Read moreDownload Whitepaper

You may also be interested in

How To Minimise the Environmental Impact of Cloud Operations

When people think about sustainability transitions in pharmaceutical supply chains, they often focus on reducing product waste, or optimising transportation. These are both important initiatives, but there's another part of the equation that often goes unnoticed: the digital infrastructure powering modern supply chains.
Read more
People seated at round tables in a conference room watching a presenter speak in front of a large screen displaying a pie chart.

Working Together to Make Clinical Trials Faster and Safer

TSS recently hosted the TSS User Forum 2025, bringing together leading experts from the life science industry to discuss how automation, data integrity, and collaboration can make temperature management in clinical trials faster, safer, and more reliable.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.